A novel protein complex distinct from mismatch repair binds thioguanylated DNA.
To elucidate molecular mechanism(s) of cellular response to mercaptopurine, a widely used antileukemic agent, we assessed mercaptopurine (MP) sensitivity in mismatch repair (MMR) proficient and MMR deficient human acute lymphoblastic leukemia (ALL) cells. Sensitivity to thiopurine cytotoxicity was not dependent on MMR (i.e., MutSalpha) competence among six cell lines tested. Using electrophoretic mobility shift assay analysis, we found that the incubation of nuclear extracts from ALL cells with synthetic 34-mer DNA duplexes containing deoxythioguanosine (G(S)) within either G(S).T or G(S).C pairs, resulted in formation of a DNA-protein complex distinct from the DNA-MutSalpha complex and unaffected by ATP. Isolation and sequence analysis of proteins involved in this DNA-protein complex identified glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a component. Western blot analysis of nuclear extracts from a panel of human lymphoblastic leukemia cell lines revealed markedly different basal levels of GAPDH in nuclei, which was significantly related to thiopurine sensitivity (p = 0.001). Confocal analysis revealed markedly different intracellular distribution of GAPDH between nucleus and cytosol in six human ALL cell lines. Redistribution of GAPDH from cytosol to nucleus was evident after MP treatment. These findings indicate that a new DNA-protein complex containing GAPDH and distinct from known MMR protein-DNA complexes binds directly to thioguanylated DNA, suggesting that this may act as a sensor of structural alterations in DNA and serve as an interface between these DNA modifications and apoptosis.
Krynetski
E Y
EY
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38163, USA.
Krynetskaia
N F
NF
Gallo
A E
AE
Murti
K G
KG
Evans
W E
WE
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D020137:Base Pair Mismatch; D002467:Cell Nucleus / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D004260:DNA Repair / Q000502:physiology*; D004268:DNA-Binding Proteins / Q000302:isolation & purification* / Q000378:metabolism; D004354:Drug Screening Assays, Antitumor; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D015122:Mercaptopurine / Q000494:pharmacology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000201:enzymology / Q000473:pathology; D013866:Thioguanine / Q000737:chemistry; D013872:Thionucleosides / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D000964:Antimetabolites, Antineoplastic; D017931:DNA Primers; D004268:DNA-Binding Proteins; D013872:Thionucleosides; D015122:Mercaptopurine; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D013866:Thioguanine